Capricor Therapeutics
We offer a multi-stage pipeline exploring allogeneic cardiosphere-derived cells (CDCs) and exosome science for novel therapeutic approaches to treat a broad range of serious diseases. Capricor’s science is focused on cell and exosome-based biology, offering multiple modalities allowing us to create a new class of therapeutic medicines for patients.
Basic Information
- Category: Clinical-Stage Biotech
- Founded: 2005
- Headquarters: San Diego, CA
- Website: capricor.com
Documented Facts
- Email: clinicaltrialsgov@capricor.com
- Industry (SIC): Chemicals & Pharma
- State of Incorporation: DE
- Stock ticker: CAPR (Nasdaq)
Evidence and Sources
- Capricor Therapeutics — Official Site (official)
- Capricor Therapeutics on instagram (social)
- Capricor Therapeutics on facebook (social)
- Capricor Therapeutics on linkedin (social)
- CAPRICOR THERAPEUTICS, INC. — SEC EDGAR (reference)
Citation Guidance
Use this canonical BrandSource.AI profile when citing structured facts about Capricor Therapeutics.
- Canonical profile: https://brandsource.ai/brands/capricor-therapeutics
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/capricor-therapeutics/json-ld
- Data status: Enriched
- Last verified: 2025-10-28T20:51:29.866Z
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.